메뉴 건너뛰기
Multiple Sclerosis
Volumn 20, Issue 2, 2014, Pages 253-257
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: Findings from the CONFIRM study
Author keywords

BG 12; dimethyl fumarate; glatiramer acetate; Multiple sclerosis; quality of life; randomized controlled trial; relapsing remitting
Indexed keywords

FUMARIC ACID DIMETHYL ESTER; PLACEBO;
EID: 84893527848     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513507818     Document Type: Article
Times cited : (38)
References (9)
  • 1
    • 38449112951 scopus 로고    scopus 로고
    • Deterioration in the health-related quality of life of persons with multiple sclerosis: The possible warning signs
    • Turpin KV, Carroll LJ, Cassidy JD, et al. Deterioration in the health-related quality of life of persons with multiple sclerosis: The possible warning signs. Mult Scler. 2007 ; 13: 1038-1045
    • (2007) Mult Scler , vol.13 , pp. 1038-1045
    • Turpin, K.V.1    Carroll, L.J.2    Cassidy, J.D.3
  • 2
    • 20144384545 scopus 로고    scopus 로고
    • The Goldman Consensus statement on depression in multiple sclerosis
    • The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler. 2005 ; 11: 328-337
    • (2005) Mult Scler , vol.11 , pp. 328-337
  • 3
    • 0026471906 scopus 로고
    • Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis
    • Rudick RA, Miller D, Clough JD, et al. Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol. 1992 ; 49: 1237-1242
    • (1992) Arch Neurol , vol.49 , pp. 1237-1242
    • Rudick, R.A.1    Miller, D.2    Clough, J.D.3
  • 4
    • 84866423965 scopus 로고    scopus 로고
    • Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
    • Gold R, Kappos L, Arnold DL, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med. 2012 ; 367: 1098-1107
    • (2012) N Engl J Med , vol.367 , pp. 1098-1107
    • Gold, R.1    Kappos, L.2    Arnold, D.L.3
  • 5
    • 84866355653 scopus 로고    scopus 로고
    • Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis
    • Fox RJ, Miller DH, Phillips JT, et al. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med. 2012 ; 367: 1087-1097
    • (2012) N Engl J Med , vol.367 , pp. 1087-1097
    • Fox, R.J.1    Miller, D.H.2    Phillips, J.T.3
  • 6
    • 0034671279 scopus 로고    scopus 로고
    • SF-36 health survey update
    • Ware JE. SF-36 health survey update. Spine. 2000 ; 25: 3130-3139
    • (2000) Spine , vol.25 , pp. 3130-3139
    • Ware, J.E.1
  • 7
    • 0032212743 scopus 로고    scopus 로고
    • The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the IQOLA Project. International Quality of Life Assessment
    • Ware JE, Gandek B, Kosinski M, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998 ; 51: 1167-1170
    • (1998) J Clin Epidemiol , vol.51 , pp. 1167-1170
    • Ware, J.E.1    Gandek, B.2    Kosinski, M.3
  • 8
    • 36148945609 scopus 로고    scopus 로고
    • Health-related quality of life in multiple sclerosis: Effects of natalizumab
    • Rudick RA, Miller D, Hass S, et al. Health-related quality of life in multiple sclerosis: Effects of natalizumab. Ann Neurol. 2007 ; 62: 335-346
    • (2007) Ann Neurol , vol.62 , pp. 335-346
    • Rudick, R.A.1    Miller, D.2    Hass, S.3
  • 9
    • 79959441293 scopus 로고    scopus 로고
    • Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: Results from a trial of intramuscular interferon {beta}-1a
    • Miller DM, Weinstock-Guttman B, Bourdette D, et al. Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: Results from a trial of intramuscular interferon {beta}-1a. Mult Scler. 2011 ; 17: 734-742
    • (2011) Mult Scler , vol.17 , pp. 734-742
    • Miller, D.M.1    Weinstock-Guttman, B.2    Bourdette, D.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.